These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains

Pfizer Inc News

These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
Ocuphire Pharma Inc,Rocket Pharmaceuticals Inc,Arvinas Inc

Stocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket Pharmaceuticals Inc, Arvinas Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 44 sec. here
  • 5 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 53%

Often enough, some biotech stocks propel through expectations and invite investor frenzy. This week, it happened to Longeveron LLC . Owing to the prospective treatment of hypoplastic left heart syndrome in the Phase 2 trial, the clinical-stage firm gained a 234% value boost over the week.

Simply put, this pioneering platform degrades proteins linked to many serious and rare diseases. Arvinas uses its Protac Discovery Engine platform to develop a drug pipeline in oncology, immuno-oncology, and pro-inflammatory rare diseases. Ocuphire’s retina drug pipeline is in the exploratory stage. The company has APX2009 for geographic atrophy and APX2014 as the second-generation drug for the treatment of retinal diseases such as age-related macular degeneration. Ocuphire will start ZETA-2 Phase 2/3 trials for APX3330 in early 2025.

The company, which is mainly focused on hematology and cardiovascular , filed a Marketing Authorisation Application for its LV RP-L102 to treat Fanconi anemia. On June 30th, the FDA is scheduled to respond to the company’s application for LV KRESLADI for the treatment of severe Leukocyte Adhesion deficiency-I .

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Investingcom /  🏆 450. in ZA
 

South Africa South Africa Latest News, South Africa South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

3 Top Stocks in the Dow Jones Worth Holding in 20243 Top Stocks in the Dow Jones Worth Holding in 2024Stocks Analysis by The Tokenist (Timothy Fries) covering: Dow Jones Industrial Average, Caterpillar Inc, Microsoft Corporation, Alphabet Inc Class A. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »

Stocks to Watch Today: J.M. Smucker, PayPal, Lululemon AthleticaStocks to Watch Today: J.M. Smucker, PayPal, Lululemon AthleticaStocks Analysis by The Tokenist (Timothy Fries) covering: JM Smucker Company, Lululemon Athletica Inc, PayPal Holdings Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »

Stocks to Watch Today: Apple, Gamestop, and First SolarStocks to Watch Today: Apple, Gamestop, and First SolarStocks Analysis by The Tokenist (Timothy Fries) covering: Apple Inc, First Solar Inc, GameStop Corp. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »

These 3 Stocks Can Surge if the Fed Cuts Rates in SeptemberThese 3 Stocks Can Surge if the Fed Cuts Rates in SeptemberStocks Analysis by The Tokenist (Timothy Fries) covering: NVIDIA Corporation, Advanced Micro Devices Inc, Natural Gas Futures, Essential Utilities Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »



Render Time: 2025-01-13 17:13:11